Can Patents Deter Innovation? The Anticommons in Biomedical Research
Michael Heller, Rebecca S. Eisenberg
Science · 1998 · 2,700 citations
No retraction on record in OpenAlex.Check Crossref now
Cite this paper
Heller, M., & Eisenberg, R. S. (1998). Can patents deter innovation? The anticommons in biomedical research. Science, 280(5364), 698–701. https://doi.org/10.1126/science.280.5364.698
In text: (Heller & Eisenberg, 1998)
Ask a question about this research
One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.
Abstract
The "tragedy of the commons" metaphor helps explain why people overuse shared resources. However, the recent proliferation of intellectual property rights in biomedical research suggests a different tragedy, an "anticommons" in which people underuse scarce resources because too many owners can block each other. Privatization of biomedical research must be more carefully deployed to sustain both upstream research and downstream product development. Otherwise, more intellectual property rights may lead paradoxically to fewer useful products for improving human health.
Related papers
- Geographic Localization of Knowledge Spillovers as Evidenced by Patent Citations1993
- Econometric Models for Count Data with an Application to the Patents-R & D Relationship1984
- Strategic alliances and interfirm knowledge transfer1996
- Knowledge and the Speed of the Transfer and Imitation of Organizational Capabilities: An Empirical Test1995
- The Simple Economics of Basic Scientific Research1959
Metadata from OpenAlex (CC0). Citations are generated from the published record.